Oppenheimer Maintains Outperform on WAVE Life Sciences, Raises Price Target to $32

Benzinga · 21h ago
Oppenheimer analyst Cheng Li maintains WAVE Life Sciences (NASDAQ:WVE) with a Outperform and raises the price target from $24 to $32.